Home Cart 0 Sign in  

[ CAS No. 2140-11-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 2140-11-6
Chemical Structure| 2140-11-6
Structure of 2140-11-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2140-11-6 ]

Related Doc. of [ 2140-11-6 ]

Alternatived Products of [ 2140-11-6 ]

Product Details of [ 2140-11-6 ]

CAS No. :2140-11-6 MDL No. :MFCD00038002
Formula : C13H16N4O5 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 308.29 Pubchem ID :-
Synonyms :
Chemical Name :9-((3aR,4R,6R,6aR)-6-(Hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-9H-purin-6-ol

Calculated chemistry of [ 2140-11-6 ]

Physicochemical Properties

Num. heavy atoms : 22
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.62
Num. rotatable bonds : 2
Num. H-bond acceptors : 8.0
Num. H-bond donors : 2.0
Molar Refractivity : 72.48
TPSA : 111.75 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.59 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.97
Log Po/w (XLOGP3) : -0.57
Log Po/w (WLOGP) : -0.38
Log Po/w (MLOGP) : -1.07
Log Po/w (SILICOS-IT) : -0.79
Consensus Log Po/w : -0.17

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.56
Solubility : 8.43 mg/ml ; 0.0274 mol/l
Class : Very soluble
Log S (Ali) : -1.31
Solubility : 15.2 mg/ml ; 0.0494 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.02
Solubility : 29.1 mg/ml ; 0.0944 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 4.3

Safety of [ 2140-11-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 2140-11-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2140-11-6 ]
  • Downstream synthetic route of [ 2140-11-6 ]

[ 2140-11-6 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 2140-11-6 ]
  • [ 39824-26-5 ]
Reference: [1] Journal of Organic Chemistry, 2008, vol. 73, # 6, p. 2416 - 2419
  • 2
  • [ 58-63-9 ]
  • [ 77-76-9 ]
  • [ 2140-11-6 ]
YieldReaction ConditionsOperation in experiment
80% With toluene-4-sulfonic acid In N,N-dimethyl-formamide for 24 h; Inert atmosphere To a solution of Inosine (0.998 g, 3.72 mmoli) in DMF (30 ml) were added 2,2-Dimethxypropane(1.8 mL, 14.59 mmoli) and p-Toluensulfonic acid monohydrate (0.038g, 0.372 mmoli). The reaction mixture was stirred under Ar for 24 h. After the evaporation of DMF, the reaction was basified with a solution of NH3 3percent and the evaporated to dryness. The residue obtained was purified by chromatography over silica gel (eluent: CH2Cl2/MeOH 95/5 v/v) to afford desiderated compound 22 as white foam (yield 80percent). 1H-NMR (200MHz, DMSO-d6) d: 1.34,1.50 (6H, s, (CH3)2C), 3.6 (2H, t, CH2-5'), 4.37 (1H, m, H-4'), 4.94 (1H, m, H-3'), 5.18 (1H, t, OH 5'), 5.37 (1H, dd, J=3.7, H-2',), 6.12 (1H, d, J=2.4, H-1'), 8.05 (1H, s, H-2), 8.32 (1H, s, H-8), 12.44 (1H, br s, NH-3). ESI MS: m/z 309.1 Da [M+H]+, C13H16N4O5 Mol. Wt. 308.29.
Reference: [1] European Journal of Medicinal Chemistry, 2012, vol. 54, p. 202 - 209
[2] Journal of Medicinal Chemistry, 2018, vol. 61, # 5, p. 2087 - 2103
[3] Journal of Medicinal Chemistry, 2008, vol. 51, # 17, p. 5349 - 5370
[4] Heterocycles, 2013, vol. 87, # 11, p. 2369 - 2384
[5] Chinese Chemical Letters, 2011, vol. 22, # 12, p. 1439 - 1442
[6] Journal of Medicinal Chemistry, 2007, vol. 50, # 4, p. 782 - 793
  • 3
  • [ 58-63-9 ]
  • [ 67-64-1 ]
  • [ 2140-11-6 ]
Reference: [1] Tetrahedron, 2009, vol. 65, # 27, p. 5228 - 5239
[2] Nucleosides, Nucleotides and Nucleic Acids, 2005, vol. 24, # 5-7, p. 881 - 885
[3] Chinese Chemical Letters, 2014, vol. 25, # 12, p. 1583 - 1585
  • 4
  • [ 58-63-9 ]
  • [ 149-73-5 ]
  • [ 2140-11-6 ]
Reference: [1] Tetrahedron Letters, 2010, vol. 51, # 49, p. 6463 - 6465
  • 5
  • [ 15888-39-8 ]
  • [ 2140-11-6 ]
Reference: [1] Journal of the Brazilian Chemical Society, 2010, vol. 21, # 5, p. 859 - 866
  • 6
  • [ 362-75-4 ]
  • [ 2140-11-6 ]
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2007, vol. 26, # 1, p. 121 - 127
Same Skeleton Products
Historical Records